News Grower

Independent coverage of AI, startups, and technology.

Ars Technica May 6, 2026 at 16:19 Big Tech Rising Hot

FDA vaccine studies censored by Trump admin after finding benefits of shots

FDA has suppressed studies on COVID-19 vaccines and Shingrix, a shingles vaccine.

Signal weather

Rising

Momentum is building quickly, so this card is a good early entry point into the topic.

By Beth Mole Original source
FDA vaccine studies censored by Trump admin after finding benefits of shots

Despite Health Secretary Robert F. Kennedy's pledge to provide "radical transparency," the agencies under his control continue to suppress scientific research that conflicts with his anti-vaccine agenda. On Tuesday, The New York Times reported confirmation from the Department of Health and Human Services that the Food and Drug Administration had blocked the publication of studies showing the safety and efficacy of vaccines against COVID-19 and shingles. The revelation follows a report from The Washington Post last month that the Centers for Disease Control and Prevention scrapped a scientifically vetted study previously scheduled for publication that found COVID-19 vaccines sharply cut the risk of emergency care and hospitalization among healthy adults. The study was ultimately rejected by Kennedy's acting CDC director, who claimed to have concerns about the study's methodology. Similarly at the FDA, two studies on COVID-19 vaccines by agency scientists were accepted for publication at medical journals, according to the Times. But unnamed FDA officials directed the agency scientists to withdraw the studies. While a preliminary abstract of one of the studies presented at a conference last fall remains online, the Times obtained a copy of the full manuscript, the conclusion of which reads, "Given the available evidence, FDA continues to conclude the benefits of vaccination outweigh the risks."Read full article Comments

Stay on the signal

Follow FDA vaccine studies censored by Trump admin after finding benefits of shots

Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.

We send a confirmation link first, then only meaningful digests.

Story map

Understand this topic fast

A quick entry into the story: why it matters now, who is involved, and where to go next for context.

Why it matters now

Fresh coverage with immediate momentum.
There are already 6 connected articles in the same storyline to continue from here.
The story keeps orbiting around Ars Technica, COVID-19, and FDA, so the entity pages are the fastest way to build context.
Ars Technica already has 4 follow-up stories on the same theme.

Topic constellation

Open the live map for this story

See which entities, story threads, sources, and follow-up articles shape this story right now.

Click nodes to continue

Entity Cluster Article Hub Source

Story timeline

Continue with this story

A short sequence of events and follow-up stories to understand the arc quickly.

May 6, 2026 at 17:20 Ars Technica

Report: SpaceX IPO gives Musk unchecked power and forbids investor lawsuits

Anyone who buys into SpaceX IPO must waive right to sue the firm, report says.

May 6, 2026 at 16:42 Ars Technica

The animated version of the iconic "Hello, world" image reveals striking new details

What's going on with those satellites, anyway?

May 6, 2026 at 16:19 Ars Technica

FDA vaccine studies censored by Trump admin after finding benefits of shots

FDA has suppressed studies on COVID-19 vaccines and Shingrix, a shingles vaccine.

May 6, 2026 at 15:44 Ars Technica

Google's Gemma 4 AI models get 3x speed boost by predicting future tokens

Up to 3x the speed with no loss of quality—is it too good to be true?

May 6, 2026 at 14:56 Ars Technica

Here's what has to happen if NASA wants to land on the Moon every month

NASA is serious about taking more shots on goal, but some of them need to start landing.

May 6, 2026 at 14:30 Ars Technica

Infants are bleeding out after parents decline vitamin K shots given at birth

Hospitals report more parents are declining vitamin K shots for their newborns.

How reliable this looks

Signal and trust for Ars Technica

This source works at a rapid pace: 100% of recent stories land in the hot window, and 0% carry visible search signal.

Trusted

Reliability

92

Freshness

100

Sources in storyline

1

Related articles

More stories that share tags, source, or category context.

More from Ars Technica

Fresh reporting and follow-up coverage from the same newsroom.

Open source page